BioWorld. Link to homepage.
BioWorld
BioWorld Science
BioWorld Asia
Data Snapshots
Biopharma
Medical technology
Infographics: Dynamic digital data analysis
Index insights
NME Digest
Special reports
Infographics: Dynamic digital data analysis
Trump administration impacts
Med-tech outlook 2026
Under threat: mRNA vaccine research
BioWorld at 35
Biopharma M&A scorecard
Bioworld 2025 review
BioWorld MedTech 2025 review
BioWorld Science 2025 review
Women's health
China's GLP-1 landscape
PFA re-energizes afib market
China CAR T
Alzheimer's disease
Coronavirus
More reports can be found here
BioWorld. Link to homepage.
Sign In
Sign Out
My Account
Subscribe
BioWorld - Thursday, April 30, 2026
Home
»
Topics
»
Disease categories and therapies
» Cancer
Cancer
RSS
MAGE-12 T-cell epitope available for licensing from NIH
Feb. 20, 2001
Available for licensing from NIH: T-cell epitopes from NY-ESO-1 cancer antigen
Feb. 20, 2001
Cyclacel to evaluate lead CDK2 inhibitor in phase I
Feb. 19, 2001
AEterna enters two commercialization alliances for Neovastat in Europe
Feb. 19, 2001
EntreMed expands phase II 2ME2 program to include prostate cancer
Feb. 19, 2001
GenVec begins phase I clinical trial with TNFerade
Feb. 16, 2001
Merck's new oligopeptide-cytotoxic agent conjugates useful for Rx of cancer, BPH
Feb. 16, 2001
Maxim receives SBIR grants for evaluation of anticancer agents
Feb. 16, 2001
SuperGen obtains certain rights to VTA technology
Feb. 16, 2001
Onconase receives orphan medicinal product designation in Europe
Feb. 15, 2001
Previous
1
2
…
3679
3680
3681
3682
3683
3684
3685
3686
3687
…
4110
4111
Next
RSS